Understanding bacterial growth mechanisms can potentially help uncover novel drug targets that are crucial for maintaining cellular viability, particularly for bacterial pathogens. In this important ...
A global commission published in the Lancet Diabetes and Endocrinology looks at the definition and diagnosis of clinical obesity. Prof Simon Griffin, Professor of General Practice, MRC Epidemiology ...
In February 2024, the FDA granted breakthrough therapy designation to NVL-520 as a treatment for patients with ROS1-positive metastatic non–small cell lung cancer (NSCLC) who received prior treatment ...